产品展示
优质供应
详细内容
| N-1315 | （（Cys31,Nva34）-Neuropeptide Y （27-36））2 | C116H186N36O28S2 | 2597.11 | 172997-92-1 | （H-Tyr-Ile-Asn-Leu-Cys-Thr-Arg-Nva-Arg-Tyr-NH2）2 （Disulfide bond） |
| N-1316 | （Pro30,Tyr32,Leu34）-Neuropeptide Y （28-36） GR231118 | C57H91N17O12 | 1206.46 | 161650-01-7 | H-Ile-Asn-Pro-Ile-Tyr-Arg-Leu-Arg-Tyr-NH2 |
| N-1317 | （His32,Leu34）-Neuropeptide Y （32-36） | C33H54N14O6 | 742.88 | 168916-68-5 | H-His-Arg-Leu-Arg-Tyr-NH2 |
| N-1318 | DL-2,7-Diaminosuberoyl-（（Tyr32,Leu34）-Neuropeptide Y （32-36））2 | C80H124N26O16 | 1706.03 | 887332-81-2 | DL-2,7-Diaminosuberoyl-（Tyr-Arg-Leu-Arg-Tyr-NH2）2 Trifluoroacetate salt |
| N-1319 | （Gly1,Ser3·22,Gln4·34,Thr6,Arg19,Tyr21,Ala23·31,Aib32）-Pancreatic Polypeptide （human） （Gly1,Gln4·16,Thr6·13,Tyr7,Asp10,Asn11,Pro14,Arg26,Met30,Ala31,Aib32）-Neuropeptide Y （human, rat） | C183H281N57O54S2 | 4207.73 | H-Gly-Pro-Ser-Gln-Pro-Thr-Tyr-Pro-Gly-Asp-Asn-Ala-Thr-Pro-Glu-Gln-Met-Ala-Arg-Tyr-Tyr-Ser-Ala-Leu-Arg-Arg-Tyr-Ile-Asn-Met-Ala-Aib-Arg-Gln-Arg-Tyr-NH2 Trifluoroacetate salt | |
| N-1320 | PYX-1 | C70H105Cl2N19O16 | 1539.63 | 140842-17-7 | Ac-3-（2,6-dichloro-Bzl）-Tyr-Ile-Asn-Leu-Ile-D-Thr-Arg-Gln-Arg-Tyr-NH2 Trifluoroacetate salt |
| N-1401 | Neurotensin | C78H121N21O20 | 1672.95 | 55508-42-4 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| N-1401-2 | （Gln4）-Neurotensin | C78H122N22O19 | 1671.96 | 61445-54-3 | Pyr-Leu-Tyr-Gln-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| N-1401-3 | （Trp11）-Neurotensin | C80H122N22O19 | 1695.99 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Trp-Ile-Leu-OH | |
| N-1401-4 | （D-Trp11）-Neurotensin | C80H122N22O19 | 1695.99 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Trp-Ile-Leu-OH Acetate salt | |
| N-1401-5 | （D-Tyr11）-Neurotensin | C78H121N21O20 | 1672.95 | 64088-62-6 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-D-Tyr-Ile-Leu-OH |
| N-1402 | Neurotensin （1-6） | C35H52N8O12 | 776.85 | 87620-09-5 | Pyr-Leu-Tyr-Glu-Asn-Lys-OH Trifluoroacetate salt |
| N-1403 | Neurotensin （1-8） | C46H71N13O14 | 1030.15 | 80887-44-1 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-OH |
| N-1404 | Neurotensin （1-11） | C66H99N19O18 | 1446.63 | 74032-89-6 | Pyr-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr-OH |
| N-1405 | Neurotensin （8-13） | C38H64N12O8 | 817.00 | 60482-95-3 | H-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| N-1405-2 | Acetyl-Neurotensin （8-13） | C40H66N12O9 | 859.04 | 74853-69-3 | Ac-Arg-Arg-Pro-Tyr-Ile-Leu-OH |
| N-1405-3 | （Dab9）-Neurotensin （8-13） | C36H60N10O8 | 760.94 | H-Arg-Dab-Pro-Tyr-Ile-Leu-OH | |
| N-1405-5 | （Lys8,Lys9）-Neurotensin （8-13） | C38H64N8O8 | 760.98 | 139026-64-5 | H-Lys-Lys-Pro-Tyr-Ile-Leu-OH |
| N-1405-6 | （Lys9,Trp11,Glu12）-Neurotensin （8-13） （Cyclic Analog） | C39H59N11O8 | 809.97 | Cyclo（-Arg-Lys-Pro-Trp-Glu）-Leu-OH | |
| N-1406 | Neurotensin （9-13） | C32H52N8O7 | 660.81 | 60482-96-4 | H-Arg-Pro-Tyr-Ile-Leu-OH |
| N-1406-2 | Boc-（Lys9）-Neurotensin （9-13）-methyl ester | C38H62N6O9 | 746.95 | Boc-Lys-Pro-Tyr-Ile-Leu-OMe Hydrochloride salt | |
| N-1501 | Brain Injury Derived Neurotrophic Peptide BINP | C62H102N18O18 | 1387.60 | H-Glu-Ala-Leu-Glu-Leu-Ala-Arg-Gly-Ala-Ile-Phe-Gln-Ala-NH2 | |
| N-1502 | Neurotrophic Factor for Retinal Cholinergic Neurons | C53H84N12O16 | 1145.32 | H-Tyr-Leu-Leu-Pro-Ala-Gln-Val-Asn-Ile-Asp-OH Trifluoroacetate salt | |
| N-1601 | Nociceptin Orphanin FQ | C79H129N27O22 | 1809.06 | 170713-75-4 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-Leu-Ala-Asn-Gln-OH Trifluoroacetate salt |
| N-1602 | Nociceptin （1-13） amide Orphanin FQ （1-13） amide | C61H100N22O15 | 1381.60 | 178064-02-3 | H-Phe-Gly-Gly-Phe-Thr-Gly-Ala-Arg-Lys-Ser-Ala-Arg-Lys-NH2 Trifluoroacetate salt |
| O-0101 | Obestatin （human） | C116H176N32O33 | 2546.87 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 Trifluoroacetate salt | |
| O-0101-2 | Biotinyl-Obestatin （human） | C126H190N34O35S | 2773.17 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Val-Gln-Tyr-Gln-Gln-His-Ser-Gln-Ala-Leu-NH2 Trifluoroacetate salt | |
| O-0102 | Obestatin （rat） | C114H174N34O31 | 2516.85 | 869705-22-6 | H-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 Trifluoroacetate salt |
| O-0102-2 | Biotinyl-Obestatin （rat） | C124H188N36O33S | 2743.15 | Biotinyl-Phe-Asn-Ala-Pro-Phe-Asp-Val-Gly-Ile-Lys-Leu-Ser-Gly-Ala-Gln-Tyr-Gln-Gln-His-Gly-Arg-Ala-Leu-NH2 Trifluoroacetate salt | |
| O-0201 | DOTA-（Tyr3）-Octreotate DOTATATE, DOTA-（Tyr3,Thr8）-Octreotide | C65H90N14O19S2 | 1435.65 | 177943-89-4 | 4,7,10-Tricarboxymethyl-1,4,7,10-tetraaza-cyclododecan-1-yl-acetyl-D-Phe-Cys-Tyr-D-Trp-Lys-Thr-Cys-L-threoninol （Disulfide bond） |
| O-0202 | Octreotide （D-Phe5,Cys6·11,D-Trp8,L-Threoninol12）-Somatostatin-14 （5-12）, SMS-201-995 | C49H66N10O10S2 | 1019.26 | 79517-01-4 | H-D-Phe-Cys-Phe-D-Trp-Lys-Thr-Cys-L-threoninol （Disulfide bond） |
| O-0203 | （[ring-D5]Phe3）-Octreotide （[ring-D5]Phe3）-SMS-201-995, （D-Phe5,Cys6·11,[ring-D5]Phe7,D-Trp8,L-Threoninol12）-Somatostatin-14 （5-12） | C49H61D5N10O10S2 | 1024.30 | 1134880-79-7 | H-D-Phe-Cys-[ring-D5]Phe-D-Trp-Lys-Thr-Cys-L-threoninol （Disulfide bond） |
| O-0301 | H-Tyr-L-1,2,3,4-tetrahydroisoquinoline-3-carboxamide · HCl | C19H21N3O3 · HCl | 375.86 | 154121-70-7 | H-Tyr-Tic-NH2 · HCl |
| O-0302 | H-Tyr-D-1,2,3,4-tetrahydroisoquinoline-3-carboxamide · HCl | C19H21N3O3 · HCl | 375.86 | 154265-38-0 | H-Tyr-D-Tic-NH2 · HCl |
| O-0401 | Hypocretin （70-98） （human） Orexin B-Gly （human） | C125H214N44O37S | 2957.41 | H-Arg-Ser-Gly-Pro-Pro-Gly-Leu-Gln-Gly-Arg-Leu-Gln-Arg-Leu-Leu-Gln-Ala-Ser-Gly-Asn-His-Ala-Ala-Gly-Ile-Leu-Thr-Met-Gly-OH |
